Dr. Alattar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Douglas Blvd #170,
Roseville, CA 95661Phone+1 855-446-8628Fax+1 916-527-0770
Education & Training
- National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2011
- MedStar Health/Harbor HospitalResidency, Internal Medicine, 2006 - 2009
- University of Al-Mustansiriyah College of MedicineClass of 1999
Certifications & Licensure
- CA State Medical License 2022 - 2026
- MD State Medical License 2009 - 2026
- KY State Medical License 2023 - 2025
- DC State Medical License 2019 - 2024
- VA State Medical License 2011 - 2024
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 3 citationsIs Testosterone Replacement Safe in Men with Cardiovascular DiseaseTalha Ahmed, May Alattar, Kevin M. Pantalone, Reyaz Haque
Cureus. 2020-03-19 - Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670Gayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan
Diabetes Care. 2014-10-01 - 59 citationsExenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 DiabetesGayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan
Diabetes Care. 2014-03-01
Journal Articles
- Elevated Amylase and Lipase in Patients Using GLP-1 Agonists or DPP-4 Inhibitors in the Outpatient SettingHoward Lando, May Alattar, Endocrine Practice, 8/2012
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: